Moreover, previous studies have shown that the incretin effect, which leads to an insulin secretion from the beta-cell following oral carbohydrate administration, is also impaired in people with obesity and ultimately in those with type 2 diabetes [26]. The gene discussed is INS; the disease is type 2 diabetes mellitus.